Januvia gets expanded FDA approval

10/17/2007 | Reuters · Wall Street Journal, The

Merck & Co.'s diabetes drug Januvia has obtained regulatory approval for use in combination with the drug metformin and with the class of drugs called sulfonylureas. Merck also added warning labels about reports of allergic reactions to Januvia, which will be allowed as initial therapy in combination with metformin, as an add-on to sulfonylureas and as an add-on to a combination of both a sulfonylurea and metformin.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Director, Corporate Counsel
Tarrytown, NY